People who have used psychedelic drugs are less likely to suffer from depression, psychological distress, or suicidal thinking, according to a new study published in the Journal of Psychopharmacology.

The research was led by Peter Hendricks, a professor of clinical psychology at the University of Alabama at Birmingham, using data from the National Survey on Drug Use and Health. Survey responses from over 190,000 adults were analyzed and the respondents were divided into two groups - lifetime psychedelic users and non-users. Lifetime users were defined as those who had ever, even once, tried DMT, ayahuasca, mescaline, psilocybin mushrooms, or LSD. 13.6% of survey respondents fell into this category (percentages have been weighted to correct for confounding variables).

Classic psychedelics remain Schedule I substances...rendering clinical research with these drugs extremely difficult to conduct. ...[Continue reading on Psychedelic Frontier]